Macit Koldas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Macit Koldas has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Kamil Şahin
Haseki Training and Research Hospital, Department of Pediatrics, University of Health Sciences
3 shared publications - Murat Elevli
Haseki Training and Research Hospital, Department of Pediatrics, University of Health Sciences
3 shared publications - Eray Metin Guler
Department of Medical Biochemistry, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey
2 shared publications Ibrahim Yilmaz
2 shared publications- Tugba Muhlise Okyay
Medical Biochemistry, University of Health Sciences, Istanbul, Türkiye
2 shared publications - Ala Üstyol
Department of Pediatric Endocrinology, Sanlıurfa Training and Research Hospital, Ministry of Health, Şanlıurfa, Turkey
1 shared publication
Latest Publications
- Open Access
- 15 April 2026
- Published by Brieflands
- Vol. 36 (2) , e166866
The Frequency of Vitamin B12 Deficiency in Newborns and Its Relationship with Methylmalonic Acid
Background: Vitamin B12 (cobalamin) is a water-soluble vitamin required for central nervous system development and myelination, as well as for the maturation of hematopoietic stem and progenitor cells. If the mother is B12-deficient, the infant’s stores will be inadequate, leading to an earlier onset of deficiency signs. Objectives: This study aimed to evaluate the frequency of B12 deficiency in newborns during the early neonatal period, to identify the lowest B12 threshold that may prompt an increase in methylmalonic acid (MMA), and to investigate the relationship between maternal and neonatal B12 levels. Methods: Mother-infant dyads who presented for delivery between November 2023 and June 2024 were screened. Newborns above 34 weeks of gestation were divided into three groups based on their serum B12 levels: Less than 200, 200 - 399, and greater than 400 pg/mL. Serum MMA was measured in newborns with B12 levels between 200 and 399 pg/mL. B12 levels were also measured in the mothers of newborns with B12 levels below 199 pg/mL. Results: Serum B12 levels of 656 newborns participating in the study were classified as low (0 - 199 pg/mL; n = 166, 25.4%), borderline (200 - 399 pg/mL; n = 370, 56.4%), and normal (≥ 400 pg/mL; n = 120, 18.2%). MMA was checked in 76 of 370 babies whose vitamin B12 values were 200-399 pg/mL. While MMA was high in 6 babies, the B12 values of these babies were as low as 206 pg/mL and as high as 367 pg/mL. In our study, a total of 52 vitamin B12 levels were measured from mothers; 28 of the 166 mothers whose infants' vitamin B12 levels were < 200 pg/mL also had vitamin B12 levels < 200 pg/mL, 21 had levels between 200 and 399 pg/mL, and 3 had levels above 400 pg/mL. Conclusions: We found that vitamin B12 was low in 25.4% of newborns and borderline in 56.4%. In this case, it is important to check the B12 status of pregnant women and, for patients with low vitamin B12 levels, to protect newborns by giving them B12-containing vitamins.
- 15 April 2026
- Published by Brieflands
- Vol. 36 (2) , e166866
Open AccessThe Frequency of Vitamin B12 Deficiency in Newborns and Its Relationship with Methylmalonic Acid
Background: Vitamin B12 (cobalamin) is a water-soluble vitamin required for central nervous system development and myelination, as well as for the maturation of hematopoietic stem and progenitor cells. If the mother is B12-deficient, the infant’s stores will be inadequate, leading to an earlier onset of deficiency signs. Objectives: This study aimed to evaluate the frequency of B12 deficiency in newborns during the early neonatal period, to identify the lowest B12 threshold that may prompt an increase in methylmalonic acid (MMA), and to investigate the relationship between maternal and neonatal B12 levels. Methods: Mother-infant dyads who presented for delivery between November 2023 and June 2024 were screened. Newborns above 34 weeks of gestation were divided into three groups based on their serum B12 levels: Less than 200, 200 - 399, and greater than 400 pg/mL. Serum MMA was measured in newborns with B12 levels between 200 and 399 pg/mL. B12 levels were also measured in the mothers of newborns with B12 levels below 199 pg/mL. Results: Serum B12 levels of 656 newborns participating in the study were classified as low (0 - 199 pg/mL; n = 166, 25.4%), borderline (200 - 399 pg/mL; n = 370, 56.4%), and normal (≥ 400 pg/mL; n = 120, 18.2%). MMA was checked in 76 of 370 babies whose vitamin B12 values were 200-399 pg/mL. While MMA was high in 6 babies, the B12 values of these babies were as low as 206 pg/mL and as high as 367 pg/mL. In our study, a total of 52 vitamin B12 levels were measured from mothers; 28 of the 166 mothers whose infants' vitamin B12 levels were < 200 pg/mL also had vitamin B12 levels < 200 pg/mL, 21 had levels between 200 and 399 pg/mL, and 3 had levels above 400 pg/mL. Conclusions: We found that vitamin B12 was low in 25.4% of newborns and borderline in 56.4%. In this case, it is important to check the B12 status of pregnant women and, for patients with low vitamin B12 levels, to protect newborns by giving them B12-containing vitamins.
- 5 October 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Serum γ-Klotho and Fibroblast Growth Factor-2 Levels in Patients with Pressure Ulcers
Introduction: This study aimed to evaluate the serum levels of γ-Klotho and fibroblast growth factor 2 (FGF2) in patients with pressure ulcers.Material and methods: Patients aged ≥18 years receiving care from Home Health Services were included. The case group consisted of individuals with stage 2–4 pressure ulcers, while the control group comprised patients without ulcers, matched for age or gender. Sociodemographic characteristics, medical device usage, and nutritional status were assessed for all participants. In the case group, additional data regarding ulcer site, stage, number, and dimensions were collected. Serum levels of γ-Klotho and FGF2 were measured using the ELISA method.Results: A total of 80 participants were enrolled (40 (50.0%) in each group). FGF2 level was 220.8 [26.8] pg/mL in the case group and 219.1 [29.1] pg/mL in the control group (p=0.577). Similarly, γ-Klotho was 1448.4 [158.6] pg/mL in the case group and 1421.3 [232.8] pg/mL in the control group (p=0.453). Conversely, a significant correlation was observed between γ-Klotho and FGF2 levels in the case group (p = 0.048), whereas no such association was found in the control group (p = 0.164). Additionally, FGF2 levels were positively associated with the number, width, and length of the wounds (p=0.003, p=0.007, and p=0.012, respectively), while a negative correlation was observed between γ-Klotho levels and wound duration (p=0.026).Conclusions: Although serum levels did not differ between groups, the exclusive correlation between γ-Klotho and FGF2 in the pressure ulcer group may indicate a role in chronic wound processes, warranting further investigation.
- 5 October 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Serum γ-Klotho and Fibroblast Growth Factor-2 Levels in Patients with Pressure Ulcers
Introduction: This study aimed to evaluate the serum levels of γ-Klotho and fibroblast growth factor 2 (FGF2) in patients with pressure ulcers.Material and methods: Patients aged ≥18 years receiving care from Home Health Services were included. The case group consisted of individuals with stage 2–4 pressure ulcers, while the control group comprised patients without ulcers, matched for age or gender. Sociodemographic characteristics, medical device usage, and nutritional status were assessed for all participants. In the case group, additional data regarding ulcer site, stage, number, and dimensions were collected. Serum levels of γ-Klotho and FGF2 were measured using the ELISA method.Results: A total of 80 participants were enrolled (40 (50.0%) in each group). FGF2 level was 220.8 [26.8] pg/mL in the case group and 219.1 [29.1] pg/mL in the control group (p=0.577). Similarly, γ-Klotho was 1448.4 [158.6] pg/mL in the case group and 1421.3 [232.8] pg/mL in the control group (p=0.453). Conversely, a significant correlation was observed between γ-Klotho and FGF2 levels in the case group (p = 0.048), whereas no such association was found in the control group (p = 0.164). Additionally, FGF2 levels were positively associated with the number, width, and length of the wounds (p=0.003, p=0.007, and p=0.012, respectively), while a negative correlation was observed between γ-Klotho levels and wound duration (p=0.026).Conclusions: Although serum levels did not differ between groups, the exclusive correlation between γ-Klotho and FGF2 in the pressure ulcer group may indicate a role in chronic wound processes, warranting further investigation.
- Open Access
- 2 October 2025
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 63 (4) , 188-194
Evaluating Cervical Cancer Risk Using Machine Learning
Evaluating Cervical Cancer Risk Using Machine Learning - The Medical Bulletin of Haseki
- 2 October 2025
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 63 (4) , 188-194
Open AccessEvaluating Cervical Cancer Risk Using Machine Learning
Evaluating Cervical Cancer Risk Using Machine Learning - The Medical Bulletin of Haseki
- Open Access
- 15 May 2025
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 24 (6) , 923-937
Machine learning-based bioactivity prediction of porphyrin derivatives: molecular descriptors, clustering, and model evaluation
Understanding the relationship between molecular structure and bioactivity is crucial for optimizing porphyrin-based therapeutics. By integrating cheminformatics techniques with machine learning models, our work enables the efficient classification of compounds based on their molecular structures and their growth inhibition capabilities (IC50). A dataset of 317 porphyrin derivatives was compiled, incorporating molecular descriptors and biological activity data. Descriptive statistical analysis was performed to examine compound distribution and key features. Clustering analysis was conducted using hierarchical clustering and fingerprint similarity matrices to classify compounds based on structural similarity. Lipinski’s Rule of Five was applied to assess drug-likeness, while Murcko scaffold analysis identified core structural patterns. Tumor response data were analyzed to evaluate therapeutic efficacy. Machine learning models were implemented to predict bioactivity. Descriptive statistics highlighted bioactive compounds, with TMPyP4 and Temaporfin being the most studied. Quantitative estimation of drug-likeness and the number of aliphatic carboxylic acids were identified as the most influential descriptors among others for bioactivity. Hierarchical clustering segmented porphyrins into nine structural groups. The analysis identified 168 pIC50 active compounds, with 31 meeting Lipinski’s criteria, and 11 overlapping as both effective and bioavailable. Tumor response analysis revealed three porphyrins achieving 100% response. Logistic Regression emerged as the best-performing model, achieving 83% accuracy, demonstrating robust predictive capabilities. This study successfully characterized porphyrin derivatives, reviewing key molecular features influencing bioactivity and evaluating their therapeutic potential. It highlights the potential of machine learning in predicting the biological activity status of porphyrin derivatives. Graphical abstract
- 15 May 2025
- Published by Springer Nature in Photochemical & Photobiological Sciences
- Vol. 24 (6) , 923-937
Open AccessMachine learning-based bioactivity prediction of porphyrin derivatives: molecular descriptors, clustering, and model evaluation
Understanding the relationship between molecular structure and bioactivity is crucial for optimizing porphyrin-based therapeutics. By integrating cheminformatics techniques with machine learning models, our work enables the efficient classification of compounds based on their molecular structures and their growth inhibition capabilities (IC50). A dataset of 317 porphyrin derivatives was compiled, incorporating molecular descriptors and biological activity data. Descriptive statistical analysis was performed to examine compound distribution and key features. Clustering analysis was conducted using hierarchical clustering and fingerprint similarity matrices to classify compounds based on structural similarity. Lipinski’s Rule of Five was applied to assess drug-likeness, while Murcko scaffold analysis identified core structural patterns. Tumor response data were analyzed to evaluate therapeutic efficacy. Machine learning models were implemented to predict bioactivity. Descriptive statistics highlighted bioactive compounds, with TMPyP4 and Temaporfin being the most studied. Quantitative estimation of drug-likeness and the number of aliphatic carboxylic acids were identified as the most influential descriptors among others for bioactivity. Hierarchical clustering segmented porphyrins into nine structural groups. The analysis identified 168 pIC50 active compounds, with 31 meeting Lipinski’s criteria, and 11 overlapping as both effective and bioavailable. Tumor response analysis revealed three porphyrins achieving 100% response. Logistic Regression emerged as the best-performing model, achieving 83% accuracy, demonstrating robust predictive capabilities. This study successfully characterized porphyrin derivatives, reviewing key molecular features influencing bioactivity and evaluating their therapeutic potential. It highlights the potential of machine learning in predicting the biological activity status of porphyrin derivatives. Graphical abstract
- 1 December 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (12) , 860-864
Assessment of cytotoxic and apoptotic properties of thymoquinone-oxime derivative on u87 glioma cells
Aim Glioblastoma, characterized by its invasive nature, stands as one of the prevalent primary malignant brain tumors. Thymoquinone (TQ) has demonstrated notable anticancer effects across various cancer types. Nevertheless, the comprehensive molecular underpinnings behind TQ’s anticancer efficacy remain partially elucidated. Given TQ’s capacity to traverse the blood-brain barrier and its selective cytotoxicity towards glioblastoma cells over primary astrocytes, it emerges as a highly promising chemotherapeutic agent for gliomas and glioblastomas. This study’s principal objective was to delve into the impact of Thymoquinone-Oxime (Ox) on cytotoxicity and apoptotic attributes within the U87 cell line. Methods Various concentrations of TQ-Ox (1.56-200 μM) were applied to the U87 glioma cell line for a 24-hour incubation period. Cytotoxicity was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, while apoptosis quantification utilized Annexin V and7-aminoactinomycin D (7-AAD) in conjunction with flow cytometry. Results Cytotoxicity assessments revealed a concentration-dependent induction by TQ-Ox across the range of 1.56 to 200 μM. Notably, TQ-Ox effectively reduced the proliferation of U87 cells, with determined IC50 doses at 193.67 μM. Furthermore, a higher rate of necrosis, constituting 73.2%, was observed at 150 μM concentration (P < .05). Conclusion Our observations propose that TQ-Ox elicits dose-dependent cytotoxic and apoptotic effects on glioma cells. Eventually, it may be a candidate compound for the treatment of brain cancer and additional in vitro and in vivo research on this TQ-Ox may be required.
- 1 December 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (12) , 860-864
Assessment of cytotoxic and apoptotic properties of thymoquinone-oxime derivative on u87 glioma cells
Aim Glioblastoma, characterized by its invasive nature, stands as one of the prevalent primary malignant brain tumors. Thymoquinone (TQ) has demonstrated notable anticancer effects across various cancer types. Nevertheless, the comprehensive molecular underpinnings behind TQ’s anticancer efficacy remain partially elucidated. Given TQ’s capacity to traverse the blood-brain barrier and its selective cytotoxicity towards glioblastoma cells over primary astrocytes, it emerges as a highly promising chemotherapeutic agent for gliomas and glioblastomas. This study’s principal objective was to delve into the impact of Thymoquinone-Oxime (Ox) on cytotoxicity and apoptotic attributes within the U87 cell line. Methods Various concentrations of TQ-Ox (1.56-200 μM) were applied to the U87 glioma cell line for a 24-hour incubation period. Cytotoxicity was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, while apoptosis quantification utilized Annexin V and7-aminoactinomycin D (7-AAD) in conjunction with flow cytometry. Results Cytotoxicity assessments revealed a concentration-dependent induction by TQ-Ox across the range of 1.56 to 200 μM. Notably, TQ-Ox effectively reduced the proliferation of U87 cells, with determined IC50 doses at 193.67 μM. Furthermore, a higher rate of necrosis, constituting 73.2%, was observed at 150 μM concentration (P < .05). Conclusion Our observations propose that TQ-Ox elicits dose-dependent cytotoxic and apoptotic effects on glioma cells. Eventually, it may be a candidate compound for the treatment of brain cancer and additional in vitro and in vivo research on this TQ-Ox may be required.
- Open Access
- 30 September 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (5) , 666-673
Impact of calcium propionate on cellular behavior in A549 and DMS114 lung cancer cell lines
Objectives: To investigate the cellular and apoptotic effects of food additive calcium propionate by in vitro methods. Methods: Cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, intracellular Glutathione (GSH) by luminometric method, mitochondrial membrane potential (MMP) by fluorometry, apoptosis by dual Acridine Orange/Ethidium Bromide (AO/EB) fluorescent staining were studied in lung cells. Results: It has been observed that calcium propionate reduced GSH and MMP levels significantly while increased cytotoxicity, apoptosis, and reactive oxygen species (ROS) levels in both A549 and DMS114 cancer cells in a dose-dependent manner. Conclusions: Cytotoxic effects of calcium propionate were more pronounced in cancer cells compared to healthy cells, suggesting its potential suitability as a chemo-preventive agent.
- 30 September 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (5) , 666-673
Open AccessImpact of calcium propionate on cellular behavior in A549 and DMS114 lung cancer cell lines
Objectives: To investigate the cellular and apoptotic effects of food additive calcium propionate by in vitro methods. Methods: Cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, intracellular Glutathione (GSH) by luminometric method, mitochondrial membrane potential (MMP) by fluorometry, apoptosis by dual Acridine Orange/Ethidium Bromide (AO/EB) fluorescent staining were studied in lung cells. Results: It has been observed that calcium propionate reduced GSH and MMP levels significantly while increased cytotoxicity, apoptosis, and reactive oxygen species (ROS) levels in both A549 and DMS114 cancer cells in a dose-dependent manner. Conclusions: Cytotoxic effects of calcium propionate were more pronounced in cancer cells compared to healthy cells, suggesting its potential suitability as a chemo-preventive agent.
- Open Access
- 16 May 2023
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 33 (1) , 31-38
SARS-COV-2 infections in children: The role of fibrinogen in predicting diagnosis and severity: A retrospective cohort study
Background. Evaluating predictors of coronavirus disease 2019 (COVID-19) and severity among children may help clinicians manage the high rate of hospital admissions for suspected cases. Objectives. This study aimed to evaluate the demographic, clinical and laboratory characteristics of children during the pandemic, and determine the predictors of COVID-19 and moderate-to-severe disease. Materials and methods. This retrospective cohort study included all consecutive COVID-19 cases in patients aged <18 years who presented to the Pediatric Emergency Department at Haseki Training and Research Hospital (Istanbul, Turkey) between March 15 and May 1, 2020, and underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) analysis of oro-nasopharyngeal swabs (n = 1137). Results. The frequency of SARS-CoV-2 PCR positivity was 28.6%. The COVID-19 (+) group presented with sore throat, headache and myalgia significantly more frequently than the COVID-19 (-) group. Multivariate logistic regression models showed independent predictors of SARS-CoV-2 positivity as follows: age, contact history, lymphocyte count <1500/mm(3), and neutrophil count <4000/mm(3). In addition, higher age, neutrophil count and fibrinogen levels were independent predictors of severity. The diagnostic cutoff value for fibrinogen (370.5 mg/dL) had a sensitivity of 53.12, specificity of 83.95, positive predictive value (PPV) of 39.53, and negative predictive value (NPV) of 90.07 for predicting severity. Conclusions. Symptomatology, whether alone or in combination with other approaches, may be an appropriate strategy to guide the diagnosis and management of COVID-19.
- 16 May 2023
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 33 (1) , 31-38
Open AccessSARS-COV-2 infections in children: The role of fibrinogen in predicting diagnosis and severity: A retrospective cohort study
Background. Evaluating predictors of coronavirus disease 2019 (COVID-19) and severity among children may help clinicians manage the high rate of hospital admissions for suspected cases. Objectives. This study aimed to evaluate the demographic, clinical and laboratory characteristics of children during the pandemic, and determine the predictors of COVID-19 and moderate-to-severe disease. Materials and methods. This retrospective cohort study included all consecutive COVID-19 cases in patients aged <18 years who presented to the Pediatric Emergency Department at Haseki Training and Research Hospital (Istanbul, Turkey) between March 15 and May 1, 2020, and underwent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) analysis of oro-nasopharyngeal swabs (n = 1137). Results. The frequency of SARS-CoV-2 PCR positivity was 28.6%. The COVID-19 (+) group presented with sore throat, headache and myalgia significantly more frequently than the COVID-19 (-) group. Multivariate logistic regression models showed independent predictors of SARS-CoV-2 positivity as follows: age, contact history, lymphocyte count <1500/mm(3), and neutrophil count <4000/mm(3). In addition, higher age, neutrophil count and fibrinogen levels were independent predictors of severity. The diagnostic cutoff value for fibrinogen (370.5 mg/dL) had a sensitivity of 53.12, specificity of 83.95, positive predictive value (PPV) of 39.53, and negative predictive value (NPV) of 90.07 for predicting severity. Conclusions. Symptomatology, whether alone or in combination with other approaches, may be an appropriate strategy to guide the diagnosis and management of COVID-19.
- Open Access
- 3 August 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (8) , 536-543
Low serum corin levels predict end-organ damage in patients with hypertensive crisis
The study aimed to investigate the predictive power of serum corin levels for distinguishing between hypertensive urgency (HU) and hypertensive emergency (HE) in patients with hypertensive crisis (HC) admitted to the emergency department. A total of 120 consecutive consenting adult patients diagnosed with HC and 55 age- and sex-matched healthy controls were enrolled. Blood pressure measurements [(systolic, diastolic, and mean arterial pressure (MAP)] and the evidence of end-organ damage at the first admission were recorded. Patients with HC were classified as patients with HE or HU according to the presence or absence of acute end-organ damage. Serum corin levels were compared between the 2 groups. The mean serum corin level was significantly lower in the HC group than in the control group; it was also lower in the HE group than in the HU group (p<0.001 for all). In the HE group, clinical features associated with end-organ damage included ST-elevation myocardial infarction (n=28, 46.7%), hemorrhagic stroke (n=11, 18.3%), ischemic stroke (n=11, 18.3%), and non–ST-elevation myocardial infarction (n=10, 16.7%). The receiving operator characteristic (ROC) analysis identified a serum corin cutoff value of 45 pg/mL for distinguishing patients with HE from patients with HU with 98.3% sensitivity and 95% specificity. Our findings suggest that serum corin levels play an important role in regulating blood pressure and are involved in the pathogenesis of HC. Low serum corin levels may predict end-organ damage and serve as a guide for diagnostic decision making in patients with HC.
- 3 August 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (8) , 536-543
Open AccessLow serum corin levels predict end-organ damage in patients with hypertensive crisis
The study aimed to investigate the predictive power of serum corin levels for distinguishing between hypertensive urgency (HU) and hypertensive emergency (HE) in patients with hypertensive crisis (HC) admitted to the emergency department. A total of 120 consecutive consenting adult patients diagnosed with HC and 55 age- and sex-matched healthy controls were enrolled. Blood pressure measurements [(systolic, diastolic, and mean arterial pressure (MAP)] and the evidence of end-organ damage at the first admission were recorded. Patients with HC were classified as patients with HE or HU according to the presence or absence of acute end-organ damage. Serum corin levels were compared between the 2 groups. The mean serum corin level was significantly lower in the HC group than in the control group; it was also lower in the HE group than in the HU group (p<0.001 for all). In the HE group, clinical features associated with end-organ damage included ST-elevation myocardial infarction (n=28, 46.7%), hemorrhagic stroke (n=11, 18.3%), ischemic stroke (n=11, 18.3%), and non–ST-elevation myocardial infarction (n=10, 16.7%). The receiving operator characteristic (ROC) analysis identified a serum corin cutoff value of 45 pg/mL for distinguishing patients with HE from patients with HU with 98.3% sensitivity and 95% specificity. Our findings suggest that serum corin levels play an important role in regulating blood pressure and are involved in the pathogenesis of HC. Low serum corin levels may predict end-organ damage and serve as a guide for diagnostic decision making in patients with HC.
- 1 March 2020
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 58 (2) , 200-207
Efficacy of Presepsin as a Biomarker of Sepsis and Its Prognostic Value for Prediction of Mortality
- 1 March 2020
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 58 (2) , 200-207
Efficacy of Presepsin as a Biomarker of Sepsis and Its Prognostic Value for Prediction of Mortality
- 1 March 2020
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 58 (2) , 176-182
The Relationship Between Serum Vaspin Levels and the Degree of Coronary Involvement in Patients with Stable Angina Pectoris
- 1 March 2020
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 58 (2) , 176-182
The Relationship Between Serum Vaspin Levels and the Degree of Coronary Involvement in Patients with Stable Angina Pectoris